| 【英語論文】 |
| |
原著論文 |
| |
|
1. Takekuma M, Kasamatsu Y, Kado N, Kuji S, Tanaka A, Takahashi N, Abe M, Hirashima Y. Adjuvant chemotherapy versus concurrent chemotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy. Int J Clin Oncol. 2016;21:741-47 |
| |
|
2. Abe M, Hirashima Y, Kasamatsu Y, Kado N, Komeda S, Kuji S, Tanaka A, Takahashi N, Takekuma M, Hihara H, Ichikawa Y, Itonaga Y, Hirakawa T, Nasu K, Miyagi K, Murakami J, Ito K. Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase Ⅱ trail. Support Care Cancer. 2016;24:675-82. |
| |
症例報告 |
| |
|
1. Takekuma M, Wong KK, Coleman RL: A long-term surviving patient with recurrent low-grade serous ovarian carcinoma treated with the MEK1/2 inhibitor, selumetinib. Gynecol Oncol Res Pract. 2016 May 5;3:5. doi: 10.1186/s40661-016-0026-5. |
| |
|
|
| 【和文論文】 |
| |
著書 |
| |
|
1. 角暢浩, 平嶋泰之. 外陰癌. 産婦人科疾患最新の治療2016-2018. 東京. 南江堂. 2016;270. |
| |
解説その他 |
| |
|
1. 笠松由佳, 安部正和, 平嶋泰之. 【婦人科悪性腫瘍規約改訂のポイントと対応ｰ 「何が｣｢なぜ｣｢どのように｣変わったのか】子宮体癌病変 間葉系腫瘍･癌肉腫の治療と管理(解説/特集). 臨床婦人科産科. 2016;70:719-24 |
